The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Denali Therapeutics Inc shares valued at $52,006 were purchased by Schuth Alexander O. on Aug 13 ’24. At $22.89 per share, Schuth Alexander O. acquired 2,272 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Ho Carole purchased 2,337 shares, netting a total of over 53,494 in proceeds.
Before that, Krognes Steve E. had sold 30,000 shares from its account. In a trade valued at $663,668, the Director traded Denali Therapeutics Inc shares for $22.12 each. Upon closing the transaction, the insider’s holdings decreased to 30,000 shares, worth approximately $0.77 million.
As published in their initiating research note from Citigroup on December 13, 2023, Denali Therapeutics Inc [DNLI] has been a Buy and the price target has been revised to $32. Earlier on September 06, 2023, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for DNLI stock.
Analyzing DNLI Stock Performance
During the last five days, there has been a surge of approximately 3.69%. Over the course of the year, Denali Therapeutics Inc shares have jumped approximately 4.75%. Shares of the company reached a 52-week high of $25.24 on 07/31/24 and a 52-week low of $14.56 on 04/25/24. A 50-day SMA is recorded $22.30, while a 200-day SMA reached $19.72. Nevertheless, trading volume fell to 1.11 million shares from 0.78 million shares the previous day.
Support And Resistance Levels for Denali Therapeutics Inc (DNLI)
According to the 24-hour chart, there is a support level at 22.09, which, if violated, would cause prices to drop to 21.70. In the upper region, resistance lies at 23.03. The next price resistance is at 23.58. RSI (Relative Strength Index) is 49.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.20, which suggests the price will decrease in the coming days. Percent R is at 50.18%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
